Alcohol Dependence is Associated with Blunted Dopamine Transmission in the Ventral Striatum
Overview
Authors
Affiliations
Background: A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride.
Methods: Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans.
Results: [11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups.
Conclusions: Alcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.
Farahbakhsh Z, Holleran K, Sens J, Fordahl S, Mauterer M, Lopez A Nat Commun. 2025; 16(1):1944.
PMID: 39994195 PMC: 11850823. DOI: 10.1038/s41467-025-56715-y.
Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder.
Klausen M, Knudsen G, Vilsboll T, Fink-Jensen A Basic Clin Pharmacol Toxicol. 2025; 136(3):e70004.
PMID: 39891507 PMC: 11786240. DOI: 10.1111/bcpt.70004.
Chumin E, Dzemidzic M, Yoder K Addict Biol. 2024; 29(11):e70008.
PMID: 39576234 PMC: 11583815. DOI: 10.1111/adb.70008.
Worhunsky P, Mignosa M, Gallezot J, Pittman B, Nabulsi N, Stryjewski A Biol Psychiatry. 2024; 97(6):651-658.
PMID: 39395473 PMC: 11839384. DOI: 10.1016/j.biopsych.2024.09.028.
Association of Neuromelanin-Sensitive MRI Signal With Lifetime Substance Use in Young Women.
Perlman G, Wengler K, Moeller S, Kotov R, Klein D, Weinstein J Am J Psychiatry. 2024; 181(11):997-1005.
PMID: 39380373 PMC: 11637462. DOI: 10.1176/appi.ajp.20220819.